Consumer Health Healthcare
Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report
A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...
September 10, 2024 | Report
Antabio Completes Phase 1 Trial of MEM-ANT3310, Advancing Novel Antibacterial Treatment for Drug-Resistant Infections
Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a pa...
September 06, 2024 | News
Gender Disparities and Adherence Challenges Uncovered in Cardiovascular Disease Care: New Insights from Daiichi Sankyo
ifferences in cardiovascular disease (CVD) care have been identified, impacting clinical outcomes: There are gender differences in CVD care, spe...
September 03, 2024 | News
Thermo Fisher Scientific Expands Asian Operations with New Business Services Center in the Philippines
Thermo Fisher Scientific, the world leader in serving science, has announced the opening of a new Global Business Services Center (GBSC) in the Philippines...
September 03, 2024 | News
Sanyou Biopharmaceuticals Introduces Comprehensive Monkeypox Product Line Featuring Antigens, Monoclonal Antibodies, and Overexpression Cell Lines
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of a comprehensive product line targeting monkeypox, which includes antigens, monoclona...
September 02, 2024 | News
Guardant Health Japan Secures MHLW Approval for Guardant360® CDx as First Blood-Based Companion Diagnostic for EGFR Exon 20 NSCLC Mutations
Guardant Health Japan , a leading precision oncology company, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan&nbs...
August 30, 2024 | News
UTime Signs NDA for Strategic Acquisition of Bowen Therapeutics Lab to Boost Global Vaccine Development
UTime Limited has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for th...
August 29, 2024 | News
Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity
Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...
August 28, 2024 | News
Shilpa Medicare Completes Phase 1 Trial for sRbumin®, India’s First Recombinant Human Albumin
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship prod...
August 28, 2024 | News
KARL STORZ and FUJIFILM Healthcare Partner to Enhance GI Endoscopy and OR Integration
KARL STORZ United States, a global leader in Operating Room (OR) integration, has teamed up with FUJIFILM Healthcare Americas Corporation (Fujifilm), a lea...
August 27, 2024 | News
Alzheimer's Association Applauds U.K.'s Approval of Leqembi® Amidst Concerns Over NHS Access Denial
The Alzheimer's Association welcomes decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqem...
August 23, 2024 | News
Getinge Enters Organ Preservation Market with Acquisition of Paragonix Technologies
With the acquisition of Paragonix Technologies – a pioneer and innovator in organ transport and preservation – Getinge marks its entry into a r...
August 23, 2024 | News
Strategic Vision Meets Execution: Glen Godresse's Bold Moves in His First 100 Days as CEO of Menarini Asia-Pacific
In a candid conversation with BioPharma APAC, Glen Godresse, CEO of Menarini Asia-Pacific, reflects on his first 100 days at the helm, highlighting...
August 23, 2024 | Interview
GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific
GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...
August 22, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
